The induction of oxidative stress, reduction of BDNF and serotonin, and attenuation of CREB signaling by prenatal exposure to a supra-therapeutic dose of buprenorphine provides evidence of a potential mechanism for the development of depression-like neurobehaviors. This evidence concerns the gene BDNF and depressive symptom measurement.